Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Blood|May 7, 2013
Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody responsePeter Aka, Maria Candida Vila, Amar Jariwala, et al.Scientific Reports|January 18, 2014
Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in MalawiW Thomas Johnston, Nora Mutalima, David Sun, et al.The European Respiratory Journal|April 4, 2024
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programmeDavid J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2015
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, et al.Malaria Journal|March 22, 2017
Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern UgandaMarlena Maziarz, Tobias Kinyera, Isaac Otim, et al.Journal of Asthma and Allergy|November 17, 2021
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary CareJohn Busby, David Price, Riyad Al-Lehebi, et al.Annals of Internal Medicine|November 24, 2015
Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized TrialAnita Kohli, Sarah Kattakuzhy, Sreetha Sidharthan, et al.Ebiomedicine|October 17, 2017
Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization StudyIsmail D Legason, Ruth M Pfeiffer, Krizia-Ivana Udquim, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Development and validation of the Risk of Exacerbation in Severe Asthma (RESA) modelWenjia Chen, Tae Yoon Lee, David Price, et al.American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.Pageof 6